Loading Events

Clearing the Air About Lung Cancer in Women

  • This event has passed.

November 17, 2023 @ 3:00 pm - 3:45 pm EST

Diagnostic tests and procedures offer opportunities to detect diseases, monitor disease progression, guide treatments, and evaluate treatment effectiveness. Some diagnostic tests are invasive, such as a biopsy or endoscopy; whereas others are noninvasive, such as x-rays and ultrasound imaging procedures.

Innovations in diagnostics provide access to health information, helping women make informed decisions about their health care at every stage of their lives. Screening and diagnostic testing can lead to earlier detection of disease, improve health outcomes, and contribute toward reducing health disparities among women. Research seeking to expand the development and availability of diagnostic tools for conditions that exclusively, differently, or disproportionately affect women is invaluable in furthering women’s health across sectors.

The Society for Women’s Health Research (SWHR) hosted a series of public forums to share educational information about the importance and value of innovative diagnostics throughout the lifespan and across disease states and conditions. The events discusses how to improve health outcomes for diseases and conditions that disproportionately or differently affect women, with special a focus on cancer and healthy aging.


The 2023 SWHR Value of Diagnostics within Women’s Health series includes:


Follow the conversation on Twitter at @SWHR and #SWHRtalksDiagnostics.

This event is free and open to the public.


November 17, 2023
3:00 pm - 3:45 pm EST
Event Categories:
, , , ,




  • Discuss the impacts of lung cancer on women’s health, including disparities in disease burden, mortality, and access to care
  • Provide an overview of key diagnostic considerations and disease management in women
  • Emphasize ways to empower women to adopt healthy habits that may prevent disease or delay progression
  • Highlight health care policies that present barriers to access to quality care and coverage


Raphael Bueno, MD

Chief, Division of Thoracic and Cardiac Surgery, Brigham and Women's Hospital

Raphael Bueno, MD

Chief, Division of Thoracic and Cardiac Surgery, Brigham and Women's Hospital

Dr. Raphael Bueno is Chief of the Division of Thoracic and Cardiac Surgery at Brigham and Women’s Hospital and co-director of the BWH Lung Center. He serves as senior surgeon at Dana-Farber Brigham Cancer Center and Brigham and Women’s Faulkner Hospital. 

As Chief of thoracic surgery and professor of surgery at Harvard Medical School, Dr. Bueno is a National Cancer Institute-funded investigator who combines translational research with a general thoracic surgery practice. Dr. Bueno’s primary research involves the development of novel translational tools in genomics that can be used to identify candidate predictive and diagnostic markers for cancer, as well as novel targets for therapy, specifically mesothelioma and lung cancer. Dr. Bueno led a BWH thoracic surgery team to Israel to complete the country’s first minimally invasive esophagectomies and teach Israeli surgeons how to perform these procedures. In 2013, Dr. Bueno performed the world’s first Image-guided Video-Assisted Thoracic Surgery (iVATS) procedure on a lung cancer patient. 

Board certified in general surgery, thoracic surgery and surgical critical care, Dr. Bueno earned his medical degree at Harvard Medical School where he received the Henry A. Christian award, named after Peter Bent Brigham Hospital’s first physician-in-chief. Dr. Bueno began his graduate medical training as an intern in surgery at BWH, followed by a surgical residency. He completed a cardiothoracic residency at Massachusetts General Hospital and was recruited back to the Brigham to establish a thoracic surgery practice and research laboratory. With clinical interests in mesothelioma, esophageal surgery, airway surgery, and thoracic outlet syndrome, Dr. Bueno has been listed as one of America’s Top Doctors by Castle Connolly and named a top thoracic surgeon by Boston Magazine. 

Erika Sward

National Assistant Vice President of Advocacy, American Lung Association

Erika Sward

National Assistant Vice President of Advocacy, American Lung Association

Erika Sward is National Assistant Vice President of Advocacy for the American Lung Association. In this capacity, she oversees federal and state policy on access to care, lung health and lung disease, and tobacco control policy issues for the Lung Association. She also serves as the Lung Association’s lead lobbyist with Congress and the Administration on access to care, tobacco control, appropriations, and lung disease and lung health issues.

Sward is a media spokesperson for the American Lung Association, speaking on a variety of topics – from e-cigarettes to tobacco cessation coverage to FDA regulation of tobacco products. She is regularly interviewed by Politico, CNN and other publications. She has also appeared on ABC, CBS, CNN, NBC and other networks.

Prior to joining the American Lung Association’s Washington National Office in 2006, Sward served as Associate Director for Advocacy at the Campaign for Tobacco-Free Kids, where she primarily worked on advancing federal legislation and policy. Sward was also an analyst for Greenberg Quinlan Rosner Research, a survey research firm, from 1999 to 2003.

Originally from Ohio, Sward received her BA in Political Science and MA in American Politics from American University. She and her husband live in Maryland with their two children, cat and their pandemic rescue dog.


Support for this educational program has been provided by Roche. SWHR maintains independence and editorial control over program development, content, and work products.